About Xylopia Labs Private Limited
Data last updated:
Xylopia Labs Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 06 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2019PTC106443. Its GSTIN is 24AAACX2845B1ZQ (Gujarat).
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Vijay Vinod Patel and Mukesh Raojibhai Patel.
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No. 377/1B Beside Udhyan Bungalow Off. S.G. Highway Iscon Cross Roads, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.06 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.71 Cr (net margin 4.9%) and EBITDA of ₹5.44 Cr (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
The company has about 111 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Xylopia. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2020. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Jasmine Bio Labs Private Limited with revenue of ₹38.87 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xylopialabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSurvey No. 377/1B Beside Udhyan Bungalow Off. S.G. Highway Iscon Cross Roads, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Xylopia Labs Private Limited
Xylopia Labs operates one associated brand: Xylopia. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drug development and dosage form research services in pharmaceuticals. | xylopialabs.com |
Business Activity of Xylopia Labs Private Limited
The main business activity of Xylopia Labs is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Xylopia Labs Private Limited FY 2025 filings available
Xylopia Labs Private Limited reported revenue of ₹35.06 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Xylopia Labs Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 8% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Xylopia Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.44 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.71 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Xylopia Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Xylopia Labs are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Xylopia Labs Private Limited
Xylopia Labs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Vinod Patel Also directs: Remaxable Enterprises LLP, Sonder Private Limited, Vitely Corp Private Limited and 2 more | Director | 06 Feb 2019 | 7 Years 8 Months | Current |
| Mukesh Raojibhai Patel Also directs: Solvius LLP, Cadmach Machinery Company Private Limited | Director | 06 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Xylopia Labs Private Limited
Xylopia Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jasmine Bio Labs Private Limited | ₹38.87 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Telangana, India |
| Sotax India Private Limited | ₹38.18 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Thane, Maharashtra, India |
| Ms Clinical Research Private Limited | ₹37.01 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Bangalore, Karnataka, India |
| Synergen Bio Private Limited | ₹36.01 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | Pune, Maharashtra, India |
| Inventys Research Company Private Limited | ₹35.6 Cr (FY 2025) | •••• | •••• | -66.0% | •••• | Mumbai, Maharashtra, India |
| Xylopia Labs Private Limited this company | ₹35.06 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Vergo Pharma Research Private Limited | ₹34.4 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Tiswadi, Goa, India |
| Perrigo Laboratories India Private Limited | ₹33.99 Cr (FY 2022) | •••• | •••• | -14.0% | •••• | Thane, Maharashtra, India |
| Novitium Labs Private Limited | ₹33.8 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Chennai, Tamil Nadu, India |
| Intonation Research Laboratories Private Limited | ₹33.31 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Hyderabad, Telangana, India |
| Generex Pharmassist Private Limited | ₹33.09 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Xylopia Labs by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Xylopia Labs Private Limited
Xylopia Labs Private Limited is audited by TALATI & TALATI for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TALATI & TALATI | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Xylopia Labs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Xylopia Labs Private Limited
Xylopia Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Xylopia Labs Private Limited
Xylopia Labs Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2020.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Gira Trust, Cliantha Trust Seller: 2 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Xylopia Labs Private Limited
Xylopia Labs Private Limited has a workforce of 111 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Xylopia Labs Private Limited
Xylopia Labs Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mukesh Raojibhai Patel was appointed as Director on 06 Feb 2019.
Credit Ratings, Litigation & Regulatory Alerts for Xylopia Labs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Xylopia Labs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Xylopia Labs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Xylopia Labs Private Limited
Xylopia Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACX2845B1ZQ | Gujarat | Active | 06 Feb 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Xylopia Labs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xylopia Labs Private Limited
Xylopia Labs is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 06 February 2019 (7+ years old) and is registered under CIN U73100GJ2019PTC106443.
Xylopia Labs reported revenue of ₹35.06 Cr for FY 2025 (up 8% YoY).
Xylopia Labs has 2 current directors:
- Vijay Vinod Patel - Director
- Mukesh Raojibhai Patel - Director
Xylopia Labs reported a net profit of ₹1.71 Cr (net margin 4.9%) and EBITDA of ₹5.44 Cr (EBITDA margin 15.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Xylopia Labs is 5% over three years and 4% over five years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Xylopia Labs is 24AAACX2845B1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Xylopia Labs is U73100GJ2019PTC106443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xylopia Labs was incorporated on 06 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Xylopia Labs has 1 deal on record (1 secondary share transfer); the latest was in March 2020.
The peers of Xylopia Labs by revenue are Jasmine Bio Labs Private Limited, Sotax India Private Limited, Ms Clinical Research Private Limited, Synergen Bio Private Limited, Inventys Research Company Private Limited and 5 more, all in the Pharma industry (Contract Research).
Mukesh Raojibhai Patel was appointed as Director on 06 Feb 2019. Vijay Vinod Patel was appointed as Director on 06 Feb 2019.